Coming Soon
Physician-Guided Peptide Services | Oklahoma City
Blythe Orthopedic Spine Surgery is developing a physician-guided peptide service through an outside medical and pharmacy partner. Details will be published once the program has been fully verified.
Program Overview
The program is expected to include an individualized medical evaluation, discussion of potential benefits, limitations and alternatives, prescribing when medically appropriate, payment through the participating provider, and direct shipment where legally permitted.
Specific peptides, participating clinicians, the pharmacy partner, regulatory status, and the states served will be identified and verified before this page is published. No peptide will be identified or promoted until that process is complete.
Important Disclosures
Peptide therapies offered through compounding pharmacies are not FDA-approved medications. Compounded peptides differ from FDA-approved drugs in manufacturing standards, quality controls, and regulatory oversight. "Manufactured in the United States" does not mean FDA-approved.
The FDA has specifically raised safety and compounding questions about several peptides, including BPC-157, TB-500, MOTS-C, and others. Much of the favorable evidence for these peptides remains preclinical (animal or laboratory studies). Human clinical trial data is limited.
No claims about healing musculoskeletal injuries or FDA approval will be made on this page until the partner, products, regulatory status, and evidence have been verified and reviewed.
Questions?
Contact the office for information about currently available orthobiologic services.